New US cancer drug prices rise 53% over five years
The annual price of newly-launched cancer drugs in the U.S. averaged $283,000 last year, a 53 percent increase from 2017
Stay updated with breaking news from Representative Katie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The annual price of newly-launched cancer drugs in the U.S. averaged $283,000 last year, a 53 percent increase from 2017
The annual price of newly-launched cancer drugs in the U.S. averaged $283,000 last year, a 53 percent increase from 2017
LONDON, Nov. 3 (Xinhua) -- The annual price of a newly-launched cancer drug in the United States averaged 283,000 U.S. dollars last year, a 53 percent increase from 2017, Reuters has reported.
New U.S. cancer drug prices increase 53 pct in 5 yrs: report-
The aftermath of the attempted coup at the Capitol is still being felt. Many of the perpetrators of the attack have not been held accountable, and our own